PTH and Huntington disease: Although calcium phosphate binders, vitamin D, and other medications can be combined with an appropriate DCa concentration to improve calcium, phosphorus, and parathyroid hormone (PTH) levels in HD patients, the optimal DCa for individuals undergoing long-term MHD remains controversial [7].